Clinical Trials

Showing trials with last updates posted in 2026.

NCT05836896 | RECRUITING | PHASE1
16 participants

A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-27
Start Date:
2024-02-15
Completion:
2027-06-30
Conditions
  • Neoplasms
  • Relapsed Diffuse Large B-cell Lymphoma (DLBCL)
  • Refractory Diffuse Large B-cell Lymphoma (DLBCL)
  • Multiple Myeloma, Refractory
  • Multiple Myeloma in Relapse
Interventions
  • GENETIC
No Results Yet
NCT05631743 | COMPLETED | NA
15 participants

VR-CBT With Inuit in Quebec

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-27
Start Date:
2023-07-15
Completion:
2025-04-30
Conditions
  • Emotion Regulation
Interventions
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page